Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 1/20 | 0.46 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.35 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.35 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.35 |
| ▸ | FNTA | P49354 | 1/20 | 0.34 |
| ▸ | FNTB | P49356 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | TOP2A | P11388 | 1/20 | 0.31 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.31 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.30 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
| ▸ | CRYAA | P02489 | 1/20 | 0.30 |
| ▸ | CRYAB | P02511 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29925026 | 0.89 | HSD11B1 (0.52) | HSD11B1HSD11B2ACHEPRKAG1PRKAA2 | |
| SCHEMBL4232635 | 0.89 | HSD11B1 (0.52) | HSD11B1HSD11B2ACHEPRKAG1PRKAA2 | |
| SCHEMBL4232633 | 0.89 | HSD11B1 (0.52) | HSD11B1HSD11B2ACHEPRKAG1PRKAA2 | |
| SCHEMBL4232501 | 0.77 | HSD11B1 (0.62) | HSD11B1HSD11B2ACHEPRKAG1PRKAA2 | |
| SCHEMBL4232495 | 0.77 | HSD11B1 (0.62) | HSD11B1HSD11B2ACHEPRKAG1PRKAA2 | |
| SCHEMBL24068242 | 0.76 | HSD11B1 (0.45) | HSD11B1HSD11B2ACHEPRKAG1PRKAA2 | |
| SCHEMBL24068231 | 0.76 | HSD11B1 (0.44) | HSD11B1HSD11B2ACHEPPARG | |
| SCHEMBL24068239 | 0.75 | HSD11B1 (0.43) | HSD11B1HSD11B2ACHEPPARG | |
| SCHEMBL30678790 | 0.73 | TYR (0.55) | HSD11B1HSD11B2 | |
| SCHEMBL30678739 | 0.71 | TYR (0.57) | HSD11B1HSD11B2PRKAG1PRKAA2PRKAB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210369738-A1 | PRODUCTION METHOD OF TELOMERASE ACTIVATORS AND TELOMERASE ACTIVATORS OBTAINED BY THIS METHOD | IZMIR YUKSEK TEKNOLOJI ENSTITUSU (TR) | 2021-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210369738-A1 | PRODUCTION METHOD OF TELOMERASE ACTIVATORS AND TELOMERASE ACTIVATORS OBTAINED BY THIS METHOD | TERT, TERB1, TERF2 | HSD11B1 431/4885HSD11B2 972/4885ACHE 118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.